|
ZNF280C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.94639901155369E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.210600034251E-09 |
| Normal-vs-Stage2 |
7.01890000009975E-07 |
| Normal-vs-Stage3 |
1.23810000030034E-07 |
| Normal-vs-Stage4 |
3.15660053651357E-10 |
| Stage1-vs-Stage2 |
4.424400E-01 |
| Stage1-vs-Stage3 |
4.307200E-01 |
| Stage1-vs-Stage4 |
1.096090E-02 |
| Stage2-vs-Stage3 |
8.904400E-01 |
| Stage2-vs-Stage4 |
2.512200E-01 |
| Stage3-vs-Stage4 |
1.443580E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07510000901812E-09 |
| Normal-vs-AfricanAmerican |
1.576690E-04 |
| Normal-vs-Asian |
1.83047999999797E-05 |
| Caucasian-vs-AfricanAmerican |
8.341400E-01 |
| Caucasian-vs-Asian |
8.490400E-01 |
| AfricanAmerican-vs-Asian |
7.522800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.91280000119798E-08 |
| Normal-vs-Female |
1.44180001271366E-10 |
| Male-vs-Female |
9.923000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.25489999502904E-08 |
| Normal-vs-Age(41-60Yrs) |
1.51290000527382E-08 |
| Normal-vs-Age(61-80Yrs) |
2.38599995316946E-09 |
| Normal-vs-Age(81-100Yrs) |
1.370320E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.106800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.654030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.567000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.542000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.786000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.395800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.365500E-02 |
| Classical-VS-Follicular |
4.223000E-01 |
| Classical-VS-Other |
6.545600E-01 |
| Classical-VS-Normal |
5.43239997430334E-09 |
| Tall-VS-Follicular |
1.125030E-01 |
| Tall-VS-Other |
4.701800E-01 |
| Tall-VS-Normal |
1.09059999919836E-08 |
| Follicular-VS-Other |
9.091200E-01 |
| Follicular-VS-Normal |
1.18220000000502E-06 |
| Other-VS-Normal |
1.820370E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.31089966343745E-10 |
| Normal-vs-N1 |
1.17889999995402E-06 |
| N0-vs-N1 |
8.490400E-01 |
|
|
